Role of stereotactic radiosurgery in the treatment of brain metastases

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 28, Issue 4, 2005, Pages 403-410

  Hazard, Lisa J ^a,b   Jensen, Randy L ^a   Shrieve, Dennis C ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Brain metastases; Gamma knife radiosurgery; Stereotactic radiosurgery; Whole brain radiation therapy

Indexed keywords

BRAIN METASTASIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; GAMMA KNIFE RADIOSURGERY; HUMAN; PATIENT SELECTION; RADIATION DOSE; REVIEW; STEREOTAXIC SURGERY; TREATMENT OUTCOME;

BRAIN NEOPLASMS; DEMENTIA; HUMANS; RADIATION INJURIES; RADIOSURGERY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 23244447832     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000158438.79665.bb     Document Type: Review

References (61)

1. Niranjan A, Lunsford LD. Radiosurgery: where we were, are, and may be in the third millennium. Neurosurgery. 2000;46:531-543.
2. Cairncross JG, Posner JB. The management of brain metastases. In: Walker MD, ed. Oncology of the nervous system. Boston: Martinus Nijhoff; 1983:341-377.
3. Hojo S, Hirano A. Pathology of metastases affecting the central nervous system. In: Takakura K, Sano K, Hojo S, et al, eds. Metastatic tumors of the central nervous system. Tokyo: Igaku-Shoin; 1982:5-35.
4. Posner JB. Management of brain metastases. Rev Neurol. 1992;148:477-487.
5. Walker AE, Robins M, Weinfeld FD. Epidemiology of brain tumours: the national survey of intracranial neoplasms. Neurology. 1985;35:219-226.
6. Patchell RA. The management of brain metastases. Cancer Treat Rev. 2003;29:533-540.
7. Gerosa M, Nicolato A, Foroni R, et al. The role of gamma knife radiosurgery in the treatment of primary and metastatic brain tumors. Curr Opin Oncol. 2003;15:188-196.
8. O'Neill BP, Iturria NJ, Link MJ, et al. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys. 2003;55:1169-1176.
9. Posner JB, Chenik NL. Intracranial metastases from systemic cancer. Adv Neurol. 1978;19:579-592.
10. Posner JB. Clinical manifestations of brain metastases. In: Weiss L, Gilbert HA, Posner JB, eds. Brain metastases. Boston: GK Hall; 1980: 189-207.
11. Markesbery WR, Brooks WH, Gupta GD, et al. Treatment for patients with cerebral metastases. Arch Neurol. 1978;35:754-756.
12. Ruderman NB, Hall TC. The use of corticosteroids in the palliative treatment of metastatic brain tumors. Cancer. 1965;18:298-306.
13. Weissman D. Glucocorticoid treatment for brain metastases and epidural spinal cord compression: a review. J Clin Oncol. 1988;6:543-551.
14. Patchell RA. The treatment of brain metastasis. Cancer Invest. 1996;14: 169-177.
15. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single brain metastasis to the brain. N Engl J Med. 1990;322:494-500.
16. Gasper L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37: 745-751.
17. Diener-West M, Dobbins TW, Phillips TL. Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int J Radiat Oncol Biol Phvs. 1989;16:669-673.
18. Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1980;6:1-9.
19. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998;280:1485-1489.
20. Smalley SR, Laws ER Jr, O'Fallon JR, et al. Resection for solitary brain metastasis. Role of adjuvant radiation and prognostic variables in 229 patients. J Neurosurg. 1992;77:531-540.
21. Flickinger JC, Kondziolka D, Lunsford D, et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys. 1994;28:797-802.
22. Alexander E, Moriarty TM, Davis RB, et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst. 1995;87:34-40.
23. Vecht CJ, Haaxma-Reiche H, Noordjik EM, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol. 1993;33:583-590.
24. Joseph J, Adler JR, Cox RS, et al. Linear accelerator-based stereotaxic radiosurgery for brain metastases: the influence of number of lesions on survival. J Clin Oncol. 1996;14:1085-1092.
25. Mintz AH, Kestle J, Gaspar L, et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with single cerebral metastasis. Cancer. 1996;78:1470-1476.
26. Majhail NS, Ghander S, Mehta VS, et al. Factors influencing early complications following gamma knife radiosurgery. A prospective study. Stereotact Fund Neurosurg. 2001;76:36-46.
27. Varlotto JM, Flickinger JC, Niranjan A, et al. Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2003; 57:452-464.
28. Mehta MP, Rozental JM, Levin AB, et al. Denning the role of stereotactic radiosurgery in the management of brain metastases. Int J Radiat Oncol Biol Phys. 1991;24:619-625.
29. Valery CA, Cornu P, Noel G, et al. Predictive factors of radiation necrosis after radiosurgery for cerebral metastases. Stereotact Fund Neurosurg. 2003;81:115-119.
30. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363:1665-1672.
31. Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain rumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys. 2000;47:291-298.
32. Boyd TS, Mehta MP. Stereotactic radiosurgery for brain metastases. Oncology (Huntingt). 1999;13:1397-409.
33. Mehta M, Noyes W, Craig B, et al. A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single brain metastases. Int J Radiat Oncol Biol Phys. 1997;39:445-454.
34. Rutigliano MJ, Lunsford LD, Kondziolka D, et al. The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery. 1995;37:445-455.
35. Sperduto PW, Hall WA. Radiosurgery, cost-effectiveness, gold standards, the scientific method, cavalier cowboys, and the cost of hope. Int J Radiat Oncol Biol Phys. 1996;36:511-513.
36. Bindal AK, Bindal RK, et al. Surgery versus radiosurgery in the treatment of brain metastases. J Neurosurg. 1996;84:748-754.
37. Schöggl A, Kitz K, Reddy M, et al. Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases. Acta Neurochir (Wien). 2000;142:621-626.
38. Noordijk EM, Vecht CJ, Haaxma-Reiche H, et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys. 1994;29:711-717.
39. Kondziolka D, Patel A, Lunsford LD, et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999;45: 427-434.
40. Schackert G. Surgery of brain metastases-pro and contra. Onkologie. 2002;25:480-481.
41. Pollack AE, Brown PD, Foote RL, et al. Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease. J Neurooncol. 2003;61:73-80.
42. Breneman JC, Warnick RE, Albright RE, et al. Stereotactic radiosurgery for metastatic brain tumors. Int J Oncol. 1996;8:617-624.
43. Sneed PK, Suh JH, Goetsch SJ, et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys. 2002;53:519-526.
44. Chidel MA, Suh JH, Reddy CA, et al. Application of the recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys. 2000;47:993-999.
45. Sneed PK, Lamborn KR, Forstner JM, et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys. 1999;43:549-558.
46. Pirzkall A, Debus J, Lohr F, et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol. 1998;16:3563-3569.
47. Chitapanarux I, Goss B, Vongtama R, et al. Prospective study of stereotactic radiosurgery without whole brain radiotherapy in patients with four or less brain metastases: incidence of intracranial progression and salvage radiotherapy. J Neurooncol. 2003;61:143-149.
48. Regine WF, Huhn JL, Patchell RA, et al. Risk of symptomatic brain tumour recurrence and neurologic deficit after radiosurgery in patients with newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys. 2002;52:333-338.
49. Regine WF, Scott C, Murray K, et al. Neurocognitive outcome in brain metastases patients treated with accelerated-fraction vs. accelerated hyperfraction radiation therapy: an analysis from Radiation Therapy Oncology Group Study 91-04. Int J Radiat Oncol Biol Phys. 2001;51: 711-717.
50. DeAngelis LM, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology. 1989;39:789-796.
51. So NK, O'Neill BP, Frytak S, et al. Delayed leukoencephalopathy in survivors with small cell lung cancer. Neurology. 1987;37:1198-1201.
52. Van Oosterhout AG, Boon PJ, Houx PJ, et al. Follow-up of cognitive functioning in patients with small cell lung cancer. Int J Radiat Oncol Biol Phys. 1995;31:911-914.
53. Shehata MK, Young B, Reid B, et al. Stereotactic radiosurgery of 468 brain metastases <2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys. 2004;59:87-93.
54. Weltman E, Salvajoli JV, Brandt RA, et al. Radiosurgery for brain metastases: who may not benefit? Int J Radiat Oncol Biol Phys. 2001; 51:1320-1327.
55. Lavine SD, Petrovich Z, Cohen-Gadol AA, et al. Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications. Neurosurgery. 1999;44:59-64.
56. Mori Y, Kondziolka D, Flickinger JC, et al. Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys. 1998;42:581-589.
57. Radbill AE, Fiveash JF, Falkenberg ET, et al. Initial treatment of melanoma brain metastases using gamma knife radiosurgery. Cancer. 2004;101:825-833.
58. Selek U, Chang EL, Hassenbusch SJ, et al. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys. 2004;59:1097-1106.
59. Amendola BE, Wolf AL, Coy SR, et al. Brain metastases in renal cell carcinoma: management with gamma knife radiosurgery. Cancer J. 2000;6:372-376.
60. Muacevic A, Kreth FW, Mack A, et al. Stereotactic radiosurgery without radiation therapy providing high local tumor control of multiple brain metastases from renal cell carcinoma. Minim Invasive Neurosurg. 2004; 47:203-208.
61. Sheehan JP, Sun MH, Kondziolka D, et al. Radiosurgery in patients with renal cell carcinoma metastases to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg. 2003;98:342-349.